1. Home
  2. |Insights
  3. |Landmark EU Court Ruling Annuls Anti-Dumping Measures For Lack of Injury Causation

Landmark EU Court Ruling Annuls Anti-Dumping Measures For Lack of Injury Causation

Client Alert | 2 min read | 09.28.11

In a landmark decision concerning the methodology used to establish injury causation in EU trade remedy investigations, the EU's General Court yesterday annulled anti-dumping measures that had been imposed on EU imports of bed linen from Pakistan since 2003. In Case T-199/04, the Court accepted the arguments brought on behalf of the largest Pakistani exporting producer of cotton-type bed linen, Gul Ahmed Textile Mills Ltd., by the head of Crowell & Moring's EU international trade practice, Laurent Ruessmann.

The General Court annulled Regulation (EC) No 397/2004 as far as Gul Ahmed is concerned on the grounds of a failure to establish properly a causal link between the imports subject to the investigation and injury suffered by the EU industry.  More specifically, the General Court agreed with Gul Ahmed that the Council made an error of law by failing to examine whether the abolition of previous anti-dumping duties on bed linen imports from Pakistan, and the implementation of tariff preferences in favour of Pakistan at the start of 2002, had the effect of breaking any causal link between injury suffered by the EU industry and the imports from Pakistan.

The failure of the EU institutions to examine all 'known factors other than the dumped imports which at the same time are injuring the Community industry', in accordance with the Basic Anti-dumping Regulation, meant that the injurious effects of the targeted imports would not be correctly separated and distinguished from the injurious effects of those other known factors. As a result, the EU institutions could not conclude that the injury attributed to the targeted imports was actually caused by those imports, rather than by other factors, thus calling into question the basis for imposition of the anti-dumping measures.

Overall, the decision is remarkable as only the third time the EU courts have annulled trade remedy measures due to a failure to establish properly injury causation. In terms of substance, the ruling serves to highlight and clarify the obligations of the Community institutions to perform a concrete analysis of the nature and importance of factors known to be causing injury, and to separate the injurious effects of other known factors from the impact of the targeted imports.

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....